Reuters logo
BRIEF-Cyclopharm says it is ‍conducting a fully underwritten non-renounceable pro-rata entitlement offer
June 4, 2017 / 10:59 PM / 6 months ago

BRIEF-Cyclopharm says it is ‍conducting a fully underwritten non-renounceable pro-rata entitlement offer

June 5 (Reuters) - Cyclopharm Ltd-

* ‍Conducting a fully underwritten non-renounceable pro-rata entitlement offer to raise approximately $7 million​

* Proceeds from offer will be used to complete recruitment of 240 patients required for FDA approved us clinical trial of Technegas Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below